All Stories

  1. Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma
  2. Immune modulation via T regulatory cell enhancement: disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases – An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
  3. Expansion of regulatory T cells prevents type 1 diabetes onset by inhibiting islet destruction
  4. Identification of 15 T Cell Restricted Genes Evaluates T Cell Infiltration of Human Healthy Tissues and Cancers and Shows Prognostic and Predictive Potential
  5. Evaluation of potential targets for ADCC induction against regulatory T cells in renal cell carcinoma
  6. The antibody frequently used to stain human GITR, does not bind GITR, leading to misleading results.
  7. The first‐generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue
  9. Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications
  10. Beta-carotene, telomerase activity and Alzheimer’s disease in old age subjects
  11. Telomeres Increasingly Develop Aberrant Structures in Aging Humans
  12. Comparing biologicals and small molecule drug therapies for chronic respiratory diseases
  13. GITR is an interesting target for immunotherapy of cancers, infection and autoimmune diseases
  14. Triggering of GITR expands a subset of regulatory T cells and prevents diabetes development in mice
  15. Use of regulatory T cells to treat autoimmune diseases and prevent GVHD in murine models and humans
  16. Regulatory T cells (Tregs) expressing specific Treg markers that infiltrate 9 types of human cancers
  17. The Proinflammatory Cytokine GITRL Contributes to TRAIL-mediated Neurotoxicity in the HCN-2 Human Neuronal Cell Line
  18. Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
  19. The role of GITR single-positive cells in immune homeostasis
  20. GITR: A Modulator of Regulatory and Effector T-Cell Activity, Crucial in Tumour Rejection and Autoimmune Diseases
  21. Modulation of tumor immunity: a patent evaluation of WO2015026684A1
  22. Are we Able to Harness the Immunomodulatory Power of Cytokines for Novel Autoimmune Disease Treatments?
  23. GITR+ regulatory T cells in the treatment of autoimmune diseases
  24. A focused Real Time PCR strategy to determine GILZ expression in mouse tissues
  25. Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells
  26. The Clinical Pharmacology of Past, Present, and Future Glucocorticoids
  27. The Molecular and Cellular Mechanisms Responsible for the Anti-inflammatory and Immunosuppressive Effects of Glucocorticoids
  28. Expansion of regulatory GITR+CD25low/-CD4+ T cells in systemic lupus erythematosus patients
  29. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells
  30. Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids
  31. Eicosapentaenoic Acid Activates RAS/ERK/C/EBPβ Pathway through H-Ras Intron 1 CpG Island Demethylation in U937 Leukemia Cells
  32. Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Ligand Triggering Upregulates Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 and Promotes Leukocyte Adhesion
  33. Characterization of a new regulatory CD4+ T cell subset in primary Sjogren's syndrome
  34. L-GILZ forms a complex with p53 and mdm2 and suppresses tumor growth through p53 activation
  35. Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity
  36. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways
  37. The intracellular portion of GITR enhances NGF-promoted neurite growth through an inverse modulation of Erk and NF-κB signalling
  38. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives
  39. CD8+T Cells: GITR Matters
  40. Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New
  41. GITR Gene Deletion and GITR-Fc Soluble Protein Administration Inhibit Multiple Organ Failure Induced by Zymosan
  42. CD4+CD25lowGITR+ cells: A novel human CD4+ T-cell population with regulatory activity
  43. Eicosapentaenoic Acid Demethylates a Single CpG That Mediates Expression of Tumor Suppressor CCAAT/Enhancer-binding Protein δ in U937 Leukemia Cells
  44. Glucocorticoid-Induced TNFR family Related gene (GITR) enhances dendritic cell activity
  45. The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in mice
  46. Effect of dietary saturated fatty acids on HNF-4α DNA binding activity and ApoCIII mRNA in sedentary rat liver
  47. Role of regulatory T cells in rheumatoid arthritis: facts and hypothesis
  48. Neutralization of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Reduces Spinal Cord Injury Damage in Mice
  49. Identification of regulatory T cells in systemic lupus erythematosus
  50. GITR: A Modulator of Immune Response and Inflammation
  51. The GITRL–GITR system alters TLR-4 expression on DC during fungal infection
  52. Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity
  53. Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related (GITR)-Fc Fusion Protein Inhibits GITR Triggering and Protects from the Inflammatory Response after Spinal Cord Injury
  54. Peroxisome Proliferator-Activated Receptor-α Contributes to the Anti-Inflammatory Activity of Glucocorticoids
  55. Glucocorticoid-Induced TNFR-Related Protein Lowers the Threshold of CD28 Costimulation in CD8+ T Cells
  56. Modulation of Acute and Chronic Inflammation of the Lung by GITR and its Ligand
  57. GITR/GITRL: More than an effector T cell co-stimulatory system
  58. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
  59. GITR-GITRL System, A Novel Player in Shock and Inflammation
  60. Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation
  61. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease
  62. Modulation of Pro- and Antiapoptotic Molecules in Double-Positive (CD4+CD8+) Thymocytes following Dexamethasone Treatment
  63. Proinflammatory Role of Glucocorticoid-Induced TNF Receptor-Related Gene in Acute Lung Inflammation
  64. Dietary PUFA modulate the expression of proliferation and differentiation markers in Morris 3924A hepatoma cells
  65. The Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Gene Modulates the Response to Candida albicans Infection
  66. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily
  67. Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock
  68. Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations
  69. Dietary α-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells
  70. Cathepsin D Polymorphism in Italian Elderly Subjects with Sporadic Late-Onset Alzheimer’s Disease
  71. Enhanced expression of hepatic lipogenic enzymes in an animal model of sedentariness
  72. GITR interacts with the pro-apoptotic protein Siva and induces apoptosis
  73. Oxidative Stress and Apoptosis in Immune Diseases
  74. Role of GITR in activation response of T lymphocytes
  75. Gene Structure and Chromosomal Assignment of Mouse GITR, a Member of the Tumor Necrosis Factor/Nerve Growth Factor Receptor Family
  76. Identification of three novel mRNA splice variants of GITR
  77. Design and Synthesis of Modified Quinolones as Antitumoral Acridones 1
  78. Angiotensin converting enzyme deletion allele in different kinds of dementia disorders
  79. Antitumor activity of 2,2′-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor
  80. Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients
  81. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis
  82. Short-Term Dexamethasone Treatment Modulates the Expression of the Murine TCRζ Gene Locus
  83. Dexamethasone modulates CD2 expression
  84. The 2,2′-Bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicity
  85. Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy
  86. Furanfurin and Thiophenfurin: Two Novel Tiazofurin Analogs. Synthesis, Structure, Antitumor Activity, and Interactions with Inosine Monophosphate Dehydrogenase
  87. T cell receptor ι an alternatively spliced product of the T cell receptor ζ gene
  88. Effect of dexamethasone on TCRζ gene expression
  89. Dexamethasone inhibits TCR/CD3 complex expression
  90. Chelating agents as potential antitumorals. 2-quinolylhydrazones and bis-2-quinolylhydrazones. I
  91. Dexamethasone and interleukins modulate apoptosis of murine thymocytes and peripheral T-lymphocytes
  92. 8-Aza Analogues of Deaza Purine Nucleosides. Synthesis and Biological Evaluation of 8-Aza-1-deazaadenosine and 2′-Deoxy-8-aza-1-deazaadenosine
  93. Synthesis and antitumor activity of 2-.beta.-D-ribofuranosyloxazole-4-carboxamide (oxazofurin)
  94. Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase*1
  95. Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase
  96. 3,7-Dideazapurine nucleosides. Synthesis and antitumor activity of 1-deazatubercidin and 2-chloro-2'-deoxy-3,7-dideazaadenosine